SCHEMBL6803710

SCHEMBL6803710

COc1ccc(-c2ccc(C(F)(F)F)cc2)c(C(=O)Nc2ccc3c(c2)CCN3C(=O)Cc2csc(N)n2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTTP P55157 5/20 0.42
APOB P04114 4/20 0.42
MAPT P10636 6/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TP53 P04637 2/20 0.41
RIPK1 Q13546 2/20 0.41
POLB P06746 1/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HTR2C P28335 1/20 0.39
HTR2B P41595 1/20 0.39
USP2 O75604 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6664644 0.91 AVPR2 (0.44) MAPTNPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL6804642 0.89 MTTP (0.47) MTTPAPOBMAPTTP53ALDH1A1
SCHEMBL6803963 0.87 GAA (0.44) MAPTNPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL6802265 0.87 RIPK1 (0.42) MTTPAPOBMAPTNPC1RAB9A
SCHEMBL6806284 0.82 RIPK1 (0.43) MTTPAPOBMAPTNPC1RAB9A
SCHEMBL6804506 0.81 MTTP (0.48) MTTPAPOBTP53SMO
SCHEMBL6670249 0.81 MAPT (0.42) MAPTNPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL6802994 0.81 RIPK1 (0.41) MAPTNPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL6666805 0.81 CASP3 (0.43) MTTPAPOBMAPTNPC1RAB9A
SCHEMBL6670037 0.81 AVPR2 (0.43) MAPTNPC1RAB9ASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157866-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157866-A1 Amide compounds APOB, NR1H2, NR1H3 MTTP 108/4885APOB 1/4885MAPT 4047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.